Serveur d'exploration sur la rapamycine et les champignons

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Statin-mediated inhibition of cholesterol synthesis induces cytoprotective autophagy in human leukemic cells.

Identifieur interne : 000C16 ( Main/Exploration ); précédent : 000C15; suivant : 000C17

Statin-mediated inhibition of cholesterol synthesis induces cytoprotective autophagy in human leukemic cells.

Auteurs : Urosh Vilimanovich [Serbie] ; Mihajlo Bosnjak [Serbie] ; Andrija Bogdanovic [Serbie] ; Ivanka Markovic [Serbie] ; Aleksandra Isakovic [Serbie] ; Tamara Kravic-Stevovic [Serbie] ; Aleksandar Mircic [Serbie] ; Vladimir Trajkovic [Serbie] ; Vladimir Bumbasirevic [Serbie]

Source :

RBID : pubmed:26358205

Descripteurs français

English descriptors

Abstract

Statins exhibit anti-leukemic properties due to suppression of the mevalonate pathway by the inhibition of 3-hydroxy-3-methylglutaryl coenzyme A reductase, and subsequent depletion of cholesterol, farnesylpyrophosphate, and geranylgeranylpyrophosphate. We investigated the role of autophagy, a controlled intracellular self-digestion, in the anti-leukemic action of statins. Treatment with low concentrations (≤6 µM) of statins, cholesterol depletion, and specific inhibition of cholesterol synthesis and protein farnesylation or geranylgeranylation, all inhibited proliferation of leukemic cell lines and primary leukemic cells without inducing overt cell death. Statins and agents that selectively reduce intracellular cholesterol levels, but not the inhibition of protein farnesylation or geranylgeranylation, induced autophagy in leukemic cells. The observed autophagic response was associated with the reduction of phosphorylated Akt levels in the lipid rafts, accompanied by a decrease in the activation of the main autophagy suppressor mammalian target of rapamycin (mTOR) and its substrate ribosomal p70S6 kinase (p70S6K). No significant autophagy induction and downregulation of mTOR/p70S6K activation were observed in normal leukocytes. Autophagy suppression by bafilomycin A1 or RNA interference-mediated knockdown of beclin-1 and microtubule-associated protein 1 light chain 3B induced apoptotic death in statin-treated leukemic cells, an effect attenuated by the addition of mevalonate or squalene, but not farnesylpyrophosphate or geranylgeranylpyrophosphate. Therefore, while the inhibition of cholesterol synthesis, protein farnesylation, and geranylgeranylation all contributed to anti-leukemic effects of statins, the inhibition of cholesterol synthesis was solely responsible for the induction of cytoprotective autophagy. These data indicate that combined treatment with statins and autophagy inhibitors might be potentially useful in anti-leukemic therapy.

DOI: 10.1016/j.ejphar.2015.09.004
PubMed: 26358205


Affiliations:


Links toward previous steps (curation, corpus...)


Le document en format XML

<record>
<TEI>
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">Statin-mediated inhibition of cholesterol synthesis induces cytoprotective autophagy in human leukemic cells.</title>
<author>
<name sortKey="Vilimanovich, Urosh" sort="Vilimanovich, Urosh" uniqKey="Vilimanovich U" first="Urosh" last="Vilimanovich">Urosh Vilimanovich</name>
<affiliation wicri:level="1">
<nlm:affiliation>Institute of Histology and Embryology, School of Medicine, University of Belgrade, Visegradska 26, 11000 Belgrade, Serbia.</nlm:affiliation>
<country xml:lang="fr">Serbie</country>
<wicri:regionArea>Institute of Histology and Embryology, School of Medicine, University of Belgrade, Visegradska 26, 11000 Belgrade</wicri:regionArea>
<wicri:noRegion>11000 Belgrade</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Bosnjak, Mihajlo" sort="Bosnjak, Mihajlo" uniqKey="Bosnjak M" first="Mihajlo" last="Bosnjak">Mihajlo Bosnjak</name>
<affiliation wicri:level="1">
<nlm:affiliation>Institute of Histology and Embryology, School of Medicine, University of Belgrade, Visegradska 26, 11000 Belgrade, Serbia.</nlm:affiliation>
<country xml:lang="fr">Serbie</country>
<wicri:regionArea>Institute of Histology and Embryology, School of Medicine, University of Belgrade, Visegradska 26, 11000 Belgrade</wicri:regionArea>
<wicri:noRegion>11000 Belgrade</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Bogdanovic, Andrija" sort="Bogdanovic, Andrija" uniqKey="Bogdanovic A" first="Andrija" last="Bogdanovic">Andrija Bogdanovic</name>
<affiliation wicri:level="1">
<nlm:affiliation>Clinic of Hematology, Clinical Centre of Serbia, School of Medicine, University of Belgrade, Belgrade, Serbia.</nlm:affiliation>
<country xml:lang="fr">Serbie</country>
<wicri:regionArea>Clinic of Hematology, Clinical Centre of Serbia, School of Medicine, University of Belgrade, Belgrade</wicri:regionArea>
<wicri:noRegion>Belgrade</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Markovic, Ivanka" sort="Markovic, Ivanka" uniqKey="Markovic I" first="Ivanka" last="Markovic">Ivanka Markovic</name>
<affiliation wicri:level="1">
<nlm:affiliation>Institute of Medical and Clinical Biochemistry, School of Medicine, University of Belgrade, Belgrade, Serbia.</nlm:affiliation>
<country xml:lang="fr">Serbie</country>
<wicri:regionArea>Institute of Medical and Clinical Biochemistry, School of Medicine, University of Belgrade, Belgrade</wicri:regionArea>
<wicri:noRegion>Belgrade</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Isakovic, Aleksandra" sort="Isakovic, Aleksandra" uniqKey="Isakovic A" first="Aleksandra" last="Isakovic">Aleksandra Isakovic</name>
<affiliation wicri:level="1">
<nlm:affiliation>Institute of Medical and Clinical Biochemistry, School of Medicine, University of Belgrade, Belgrade, Serbia.</nlm:affiliation>
<country xml:lang="fr">Serbie</country>
<wicri:regionArea>Institute of Medical and Clinical Biochemistry, School of Medicine, University of Belgrade, Belgrade</wicri:regionArea>
<wicri:noRegion>Belgrade</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Kravic Stevovic, Tamara" sort="Kravic Stevovic, Tamara" uniqKey="Kravic Stevovic T" first="Tamara" last="Kravic-Stevovic">Tamara Kravic-Stevovic</name>
<affiliation wicri:level="1">
<nlm:affiliation>Institute of Histology and Embryology, School of Medicine, University of Belgrade, Visegradska 26, 11000 Belgrade, Serbia.</nlm:affiliation>
<country xml:lang="fr">Serbie</country>
<wicri:regionArea>Institute of Histology and Embryology, School of Medicine, University of Belgrade, Visegradska 26, 11000 Belgrade</wicri:regionArea>
<wicri:noRegion>11000 Belgrade</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Mircic, Aleksandar" sort="Mircic, Aleksandar" uniqKey="Mircic A" first="Aleksandar" last="Mircic">Aleksandar Mircic</name>
<affiliation wicri:level="1">
<nlm:affiliation>Institute of Histology and Embryology, School of Medicine, University of Belgrade, Visegradska 26, 11000 Belgrade, Serbia.</nlm:affiliation>
<country xml:lang="fr">Serbie</country>
<wicri:regionArea>Institute of Histology and Embryology, School of Medicine, University of Belgrade, Visegradska 26, 11000 Belgrade</wicri:regionArea>
<wicri:noRegion>11000 Belgrade</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Trajkovic, Vladimir" sort="Trajkovic, Vladimir" uniqKey="Trajkovic V" first="Vladimir" last="Trajkovic">Vladimir Trajkovic</name>
<affiliation wicri:level="1">
<nlm:affiliation>Institute of Microbiology and Immunology, School of Medicine, University of Belgrade, Dr. Subotica 1, 11000 Belgrade, Serbia. Electronic address: vtrajkovic@med.bg.ac.rs.</nlm:affiliation>
<country xml:lang="fr">Serbie</country>
<wicri:regionArea>Institute of Microbiology and Immunology, School of Medicine, University of Belgrade, Dr. Subotica 1, 11000 Belgrade</wicri:regionArea>
<wicri:noRegion>11000 Belgrade</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Bumbasirevic, Vladimir" sort="Bumbasirevic, Vladimir" uniqKey="Bumbasirevic V" first="Vladimir" last="Bumbasirevic">Vladimir Bumbasirevic</name>
<affiliation wicri:level="1">
<nlm:affiliation>Institute of Histology and Embryology, School of Medicine, University of Belgrade, Visegradska 26, 11000 Belgrade, Serbia. Electronic address: v_bumbasirevic@med.bg.ac.rs.</nlm:affiliation>
<country xml:lang="fr">Serbie</country>
<wicri:regionArea>Institute of Histology and Embryology, School of Medicine, University of Belgrade, Visegradska 26, 11000 Belgrade</wicri:regionArea>
<wicri:noRegion>11000 Belgrade</wicri:noRegion>
</affiliation>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">PubMed</idno>
<date when="2015">2015</date>
<idno type="RBID">pubmed:26358205</idno>
<idno type="pmid">26358205</idno>
<idno type="doi">10.1016/j.ejphar.2015.09.004</idno>
<idno type="wicri:Area/Main/Corpus">000B90</idno>
<idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Corpus" wicri:corpus="PubMed">000B90</idno>
<idno type="wicri:Area/Main/Curation">000B90</idno>
<idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Curation">000B90</idno>
<idno type="wicri:Area/Main/Exploration">000B90</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title xml:lang="en">Statin-mediated inhibition of cholesterol synthesis induces cytoprotective autophagy in human leukemic cells.</title>
<author>
<name sortKey="Vilimanovich, Urosh" sort="Vilimanovich, Urosh" uniqKey="Vilimanovich U" first="Urosh" last="Vilimanovich">Urosh Vilimanovich</name>
<affiliation wicri:level="1">
<nlm:affiliation>Institute of Histology and Embryology, School of Medicine, University of Belgrade, Visegradska 26, 11000 Belgrade, Serbia.</nlm:affiliation>
<country xml:lang="fr">Serbie</country>
<wicri:regionArea>Institute of Histology and Embryology, School of Medicine, University of Belgrade, Visegradska 26, 11000 Belgrade</wicri:regionArea>
<wicri:noRegion>11000 Belgrade</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Bosnjak, Mihajlo" sort="Bosnjak, Mihajlo" uniqKey="Bosnjak M" first="Mihajlo" last="Bosnjak">Mihajlo Bosnjak</name>
<affiliation wicri:level="1">
<nlm:affiliation>Institute of Histology and Embryology, School of Medicine, University of Belgrade, Visegradska 26, 11000 Belgrade, Serbia.</nlm:affiliation>
<country xml:lang="fr">Serbie</country>
<wicri:regionArea>Institute of Histology and Embryology, School of Medicine, University of Belgrade, Visegradska 26, 11000 Belgrade</wicri:regionArea>
<wicri:noRegion>11000 Belgrade</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Bogdanovic, Andrija" sort="Bogdanovic, Andrija" uniqKey="Bogdanovic A" first="Andrija" last="Bogdanovic">Andrija Bogdanovic</name>
<affiliation wicri:level="1">
<nlm:affiliation>Clinic of Hematology, Clinical Centre of Serbia, School of Medicine, University of Belgrade, Belgrade, Serbia.</nlm:affiliation>
<country xml:lang="fr">Serbie</country>
<wicri:regionArea>Clinic of Hematology, Clinical Centre of Serbia, School of Medicine, University of Belgrade, Belgrade</wicri:regionArea>
<wicri:noRegion>Belgrade</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Markovic, Ivanka" sort="Markovic, Ivanka" uniqKey="Markovic I" first="Ivanka" last="Markovic">Ivanka Markovic</name>
<affiliation wicri:level="1">
<nlm:affiliation>Institute of Medical and Clinical Biochemistry, School of Medicine, University of Belgrade, Belgrade, Serbia.</nlm:affiliation>
<country xml:lang="fr">Serbie</country>
<wicri:regionArea>Institute of Medical and Clinical Biochemistry, School of Medicine, University of Belgrade, Belgrade</wicri:regionArea>
<wicri:noRegion>Belgrade</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Isakovic, Aleksandra" sort="Isakovic, Aleksandra" uniqKey="Isakovic A" first="Aleksandra" last="Isakovic">Aleksandra Isakovic</name>
<affiliation wicri:level="1">
<nlm:affiliation>Institute of Medical and Clinical Biochemistry, School of Medicine, University of Belgrade, Belgrade, Serbia.</nlm:affiliation>
<country xml:lang="fr">Serbie</country>
<wicri:regionArea>Institute of Medical and Clinical Biochemistry, School of Medicine, University of Belgrade, Belgrade</wicri:regionArea>
<wicri:noRegion>Belgrade</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Kravic Stevovic, Tamara" sort="Kravic Stevovic, Tamara" uniqKey="Kravic Stevovic T" first="Tamara" last="Kravic-Stevovic">Tamara Kravic-Stevovic</name>
<affiliation wicri:level="1">
<nlm:affiliation>Institute of Histology and Embryology, School of Medicine, University of Belgrade, Visegradska 26, 11000 Belgrade, Serbia.</nlm:affiliation>
<country xml:lang="fr">Serbie</country>
<wicri:regionArea>Institute of Histology and Embryology, School of Medicine, University of Belgrade, Visegradska 26, 11000 Belgrade</wicri:regionArea>
<wicri:noRegion>11000 Belgrade</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Mircic, Aleksandar" sort="Mircic, Aleksandar" uniqKey="Mircic A" first="Aleksandar" last="Mircic">Aleksandar Mircic</name>
<affiliation wicri:level="1">
<nlm:affiliation>Institute of Histology and Embryology, School of Medicine, University of Belgrade, Visegradska 26, 11000 Belgrade, Serbia.</nlm:affiliation>
<country xml:lang="fr">Serbie</country>
<wicri:regionArea>Institute of Histology and Embryology, School of Medicine, University of Belgrade, Visegradska 26, 11000 Belgrade</wicri:regionArea>
<wicri:noRegion>11000 Belgrade</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Trajkovic, Vladimir" sort="Trajkovic, Vladimir" uniqKey="Trajkovic V" first="Vladimir" last="Trajkovic">Vladimir Trajkovic</name>
<affiliation wicri:level="1">
<nlm:affiliation>Institute of Microbiology and Immunology, School of Medicine, University of Belgrade, Dr. Subotica 1, 11000 Belgrade, Serbia. Electronic address: vtrajkovic@med.bg.ac.rs.</nlm:affiliation>
<country xml:lang="fr">Serbie</country>
<wicri:regionArea>Institute of Microbiology and Immunology, School of Medicine, University of Belgrade, Dr. Subotica 1, 11000 Belgrade</wicri:regionArea>
<wicri:noRegion>11000 Belgrade</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Bumbasirevic, Vladimir" sort="Bumbasirevic, Vladimir" uniqKey="Bumbasirevic V" first="Vladimir" last="Bumbasirevic">Vladimir Bumbasirevic</name>
<affiliation wicri:level="1">
<nlm:affiliation>Institute of Histology and Embryology, School of Medicine, University of Belgrade, Visegradska 26, 11000 Belgrade, Serbia. Electronic address: v_bumbasirevic@med.bg.ac.rs.</nlm:affiliation>
<country xml:lang="fr">Serbie</country>
<wicri:regionArea>Institute of Histology and Embryology, School of Medicine, University of Belgrade, Visegradska 26, 11000 Belgrade</wicri:regionArea>
<wicri:noRegion>11000 Belgrade</wicri:noRegion>
</affiliation>
</author>
</analytic>
<series>
<title level="j">European journal of pharmacology</title>
<idno type="eISSN">1879-0712</idno>
<imprint>
<date when="2015" type="published">2015</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="KwdEn" xml:lang="en">
<term>Autophagy (drug effects)</term>
<term>Autophagy (physiology)</term>
<term>Cholesterol (biosynthesis)</term>
<term>Cytoprotection (drug effects)</term>
<term>Cytoprotection (physiology)</term>
<term>Dose-Response Relationship, Drug (MeSH)</term>
<term>HL-60 Cells (MeSH)</term>
<term>Humans (MeSH)</term>
<term>Hydroxymethylglutaryl-CoA Reductase Inhibitors (pharmacology)</term>
<term>K562 Cells (MeSH)</term>
<term>Leukemia (metabolism)</term>
<term>Leukemia (pathology)</term>
<term>Leukemia (prevention & control)</term>
<term>Membrane Microdomains (drug effects)</term>
<term>Membrane Microdomains (metabolism)</term>
<term>Membrane Microdomains (pathology)</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr">
<term>Autophagie (effets des médicaments et des substances chimiques)</term>
<term>Autophagie (physiologie)</term>
<term>Cellules HL-60 (MeSH)</term>
<term>Cellules K562 (MeSH)</term>
<term>Cholestérol (biosynthèse)</term>
<term>Cytoprotection (effets des médicaments et des substances chimiques)</term>
<term>Cytoprotection (physiologie)</term>
<term>Humains (MeSH)</term>
<term>Inhibiteurs de l'hydroxyméthylglutaryl-CoA réductase (pharmacologie)</term>
<term>Leucémies (anatomopathologie)</term>
<term>Leucémies (métabolisme)</term>
<term>Leucémies (prévention et contrôle)</term>
<term>Microdomaines membranaires (anatomopathologie)</term>
<term>Microdomaines membranaires (effets des médicaments et des substances chimiques)</term>
<term>Microdomaines membranaires (métabolisme)</term>
<term>Relation dose-effet des médicaments (MeSH)</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="biosynthesis" xml:lang="en">
<term>Cholesterol</term>
</keywords>
<keywords scheme="MESH" qualifier="anatomopathologie" xml:lang="fr">
<term>Leucémies</term>
<term>Microdomaines membranaires</term>
</keywords>
<keywords scheme="MESH" qualifier="biosynthèse" xml:lang="fr">
<term>Cholestérol</term>
</keywords>
<keywords scheme="MESH" qualifier="drug effects" xml:lang="en">
<term>Autophagy</term>
<term>Cytoprotection</term>
<term>Membrane Microdomains</term>
</keywords>
<keywords scheme="MESH" qualifier="effets des médicaments et des substances chimiques" xml:lang="fr">
<term>Autophagie</term>
<term>Cytoprotection</term>
<term>Microdomaines membranaires</term>
</keywords>
<keywords scheme="MESH" qualifier="metabolism" xml:lang="en">
<term>Leukemia</term>
<term>Membrane Microdomains</term>
</keywords>
<keywords scheme="MESH" qualifier="métabolisme" xml:lang="fr">
<term>Leucémies</term>
<term>Microdomaines membranaires</term>
</keywords>
<keywords scheme="MESH" qualifier="pathology" xml:lang="en">
<term>Leukemia</term>
<term>Membrane Microdomains</term>
</keywords>
<keywords scheme="MESH" qualifier="pharmacologie" xml:lang="fr">
<term>Inhibiteurs de l'hydroxyméthylglutaryl-CoA réductase</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="pharmacology" xml:lang="en">
<term>Hydroxymethylglutaryl-CoA Reductase Inhibitors</term>
</keywords>
<keywords scheme="MESH" qualifier="physiologie" xml:lang="fr">
<term>Autophagie</term>
<term>Cytoprotection</term>
</keywords>
<keywords scheme="MESH" qualifier="physiology" xml:lang="en">
<term>Autophagy</term>
<term>Cytoprotection</term>
</keywords>
<keywords scheme="MESH" qualifier="prevention & control" xml:lang="en">
<term>Leukemia</term>
</keywords>
<keywords scheme="MESH" qualifier="prévention et contrôle" xml:lang="fr">
<term>Leucémies</term>
</keywords>
<keywords scheme="MESH" xml:lang="en">
<term>Dose-Response Relationship, Drug</term>
<term>HL-60 Cells</term>
<term>Humans</term>
<term>K562 Cells</term>
</keywords>
<keywords scheme="MESH" xml:lang="fr">
<term>Cellules HL-60</term>
<term>Cellules K562</term>
<term>Humains</term>
<term>Relation dose-effet des médicaments</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">Statins exhibit anti-leukemic properties due to suppression of the mevalonate pathway by the inhibition of 3-hydroxy-3-methylglutaryl coenzyme A reductase, and subsequent depletion of cholesterol, farnesylpyrophosphate, and geranylgeranylpyrophosphate. We investigated the role of autophagy, a controlled intracellular self-digestion, in the anti-leukemic action of statins. Treatment with low concentrations (≤6 µM) of statins, cholesterol depletion, and specific inhibition of cholesterol synthesis and protein farnesylation or geranylgeranylation, all inhibited proliferation of leukemic cell lines and primary leukemic cells without inducing overt cell death. Statins and agents that selectively reduce intracellular cholesterol levels, but not the inhibition of protein farnesylation or geranylgeranylation, induced autophagy in leukemic cells. The observed autophagic response was associated with the reduction of phosphorylated Akt levels in the lipid rafts, accompanied by a decrease in the activation of the main autophagy suppressor mammalian target of rapamycin (mTOR) and its substrate ribosomal p70S6 kinase (p70S6K). No significant autophagy induction and downregulation of mTOR/p70S6K activation were observed in normal leukocytes. Autophagy suppression by bafilomycin A1 or RNA interference-mediated knockdown of beclin-1 and microtubule-associated protein 1 light chain 3B induced apoptotic death in statin-treated leukemic cells, an effect attenuated by the addition of mevalonate or squalene, but not farnesylpyrophosphate or geranylgeranylpyrophosphate. Therefore, while the inhibition of cholesterol synthesis, protein farnesylation, and geranylgeranylation all contributed to anti-leukemic effects of statins, the inhibition of cholesterol synthesis was solely responsible for the induction of cytoprotective autophagy. These data indicate that combined treatment with statins and autophagy inhibitors might be potentially useful in anti-leukemic therapy.</div>
</front>
</TEI>
<pubmed>
<MedlineCitation Status="MEDLINE" Owner="NLM">
<PMID Version="1">26358205</PMID>
<DateCompleted>
<Year>2016</Year>
<Month>08</Month>
<Day>08</Day>
</DateCompleted>
<DateRevised>
<Year>2015</Year>
<Month>10</Month>
<Day>20</Day>
</DateRevised>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Electronic">1879-0712</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>765</Volume>
<PubDate>
<Year>2015</Year>
<Month>Oct</Month>
<Day>15</Day>
</PubDate>
</JournalIssue>
<Title>European journal of pharmacology</Title>
<ISOAbbreviation>Eur J Pharmacol</ISOAbbreviation>
</Journal>
<ArticleTitle>Statin-mediated inhibition of cholesterol synthesis induces cytoprotective autophagy in human leukemic cells.</ArticleTitle>
<Pagination>
<MedlinePgn>415-28</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1016/j.ejphar.2015.09.004</ELocationID>
<ELocationID EIdType="pii" ValidYN="Y">S0014-2999(15)30237-5</ELocationID>
<Abstract>
<AbstractText>Statins exhibit anti-leukemic properties due to suppression of the mevalonate pathway by the inhibition of 3-hydroxy-3-methylglutaryl coenzyme A reductase, and subsequent depletion of cholesterol, farnesylpyrophosphate, and geranylgeranylpyrophosphate. We investigated the role of autophagy, a controlled intracellular self-digestion, in the anti-leukemic action of statins. Treatment with low concentrations (≤6 µM) of statins, cholesterol depletion, and specific inhibition of cholesterol synthesis and protein farnesylation or geranylgeranylation, all inhibited proliferation of leukemic cell lines and primary leukemic cells without inducing overt cell death. Statins and agents that selectively reduce intracellular cholesterol levels, but not the inhibition of protein farnesylation or geranylgeranylation, induced autophagy in leukemic cells. The observed autophagic response was associated with the reduction of phosphorylated Akt levels in the lipid rafts, accompanied by a decrease in the activation of the main autophagy suppressor mammalian target of rapamycin (mTOR) and its substrate ribosomal p70S6 kinase (p70S6K). No significant autophagy induction and downregulation of mTOR/p70S6K activation were observed in normal leukocytes. Autophagy suppression by bafilomycin A1 or RNA interference-mediated knockdown of beclin-1 and microtubule-associated protein 1 light chain 3B induced apoptotic death in statin-treated leukemic cells, an effect attenuated by the addition of mevalonate or squalene, but not farnesylpyrophosphate or geranylgeranylpyrophosphate. Therefore, while the inhibition of cholesterol synthesis, protein farnesylation, and geranylgeranylation all contributed to anti-leukemic effects of statins, the inhibition of cholesterol synthesis was solely responsible for the induction of cytoprotective autophagy. These data indicate that combined treatment with statins and autophagy inhibitors might be potentially useful in anti-leukemic therapy.</AbstractText>
<CopyrightInformation>Copyright © 2015 Elsevier B.V. All rights reserved.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Vilimanovich</LastName>
<ForeName>Urosh</ForeName>
<Initials>U</Initials>
<AffiliationInfo>
<Affiliation>Institute of Histology and Embryology, School of Medicine, University of Belgrade, Visegradska 26, 11000 Belgrade, Serbia.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Bosnjak</LastName>
<ForeName>Mihajlo</ForeName>
<Initials>M</Initials>
<AffiliationInfo>
<Affiliation>Institute of Histology and Embryology, School of Medicine, University of Belgrade, Visegradska 26, 11000 Belgrade, Serbia.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Bogdanovic</LastName>
<ForeName>Andrija</ForeName>
<Initials>A</Initials>
<AffiliationInfo>
<Affiliation>Clinic of Hematology, Clinical Centre of Serbia, School of Medicine, University of Belgrade, Belgrade, Serbia.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Markovic</LastName>
<ForeName>Ivanka</ForeName>
<Initials>I</Initials>
<AffiliationInfo>
<Affiliation>Institute of Medical and Clinical Biochemistry, School of Medicine, University of Belgrade, Belgrade, Serbia.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Isakovic</LastName>
<ForeName>Aleksandra</ForeName>
<Initials>A</Initials>
<AffiliationInfo>
<Affiliation>Institute of Medical and Clinical Biochemistry, School of Medicine, University of Belgrade, Belgrade, Serbia.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Kravic-Stevovic</LastName>
<ForeName>Tamara</ForeName>
<Initials>T</Initials>
<AffiliationInfo>
<Affiliation>Institute of Histology and Embryology, School of Medicine, University of Belgrade, Visegradska 26, 11000 Belgrade, Serbia.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Mircic</LastName>
<ForeName>Aleksandar</ForeName>
<Initials>A</Initials>
<AffiliationInfo>
<Affiliation>Institute of Histology and Embryology, School of Medicine, University of Belgrade, Visegradska 26, 11000 Belgrade, Serbia.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Trajkovic</LastName>
<ForeName>Vladimir</ForeName>
<Initials>V</Initials>
<AffiliationInfo>
<Affiliation>Institute of Microbiology and Immunology, School of Medicine, University of Belgrade, Dr. Subotica 1, 11000 Belgrade, Serbia. Electronic address: vtrajkovic@med.bg.ac.rs.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Bumbasirevic</LastName>
<ForeName>Vladimir</ForeName>
<Initials>V</Initials>
<AffiliationInfo>
<Affiliation>Institute of Histology and Embryology, School of Medicine, University of Belgrade, Visegradska 26, 11000 Belgrade, Serbia. Electronic address: v_bumbasirevic@med.bg.ac.rs.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2015</Year>
<Month>09</Month>
<Day>08</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>Netherlands</Country>
<MedlineTA>Eur J Pharmacol</MedlineTA>
<NlmUniqueID>1254354</NlmUniqueID>
<ISSNLinking>0014-2999</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D019161">Hydroxymethylglutaryl-CoA Reductase Inhibitors</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>97C5T2UQ7J</RegistryNumber>
<NameOfSubstance UI="D002784">Cholesterol</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName UI="D001343" MajorTopicYN="N">Autophagy</DescriptorName>
<QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName>
<QualifierName UI="Q000502" MajorTopicYN="Y">physiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D002784" MajorTopicYN="N">Cholesterol</DescriptorName>
<QualifierName UI="Q000096" MajorTopicYN="Y">biosynthesis</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D019610" MajorTopicYN="N">Cytoprotection</DescriptorName>
<QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName>
<QualifierName UI="Q000502" MajorTopicYN="Y">physiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D004305" MajorTopicYN="N">Dose-Response Relationship, Drug</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D018922" MajorTopicYN="N">HL-60 Cells</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D019161" MajorTopicYN="N">Hydroxymethylglutaryl-CoA Reductase Inhibitors</DescriptorName>
<QualifierName UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D020014" MajorTopicYN="N">K562 Cells</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D007938" MajorTopicYN="N">Leukemia</DescriptorName>
<QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
<QualifierName UI="Q000473" MajorTopicYN="Y">pathology</QualifierName>
<QualifierName UI="Q000517" MajorTopicYN="N">prevention & control</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D021962" MajorTopicYN="N">Membrane Microdomains</DescriptorName>
<QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName>
<QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
<QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName>
</MeshHeading>
</MeshHeadingList>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">Apoptosis</Keyword>
<Keyword MajorTopicYN="N">Atorvastatin (PubChem CID: 60823)</Keyword>
<Keyword MajorTopicYN="N">Autophagy</Keyword>
<Keyword MajorTopicYN="N">Cholesterol</Keyword>
<Keyword MajorTopicYN="N">FTI-227 (PubChem CID: 3005532)</Keyword>
<Keyword MajorTopicYN="N">Farnesylpyrophosphate (PubChem CID: 44134714)</Keyword>
<Keyword MajorTopicYN="N">GGTI-2133 (PubChem CID: 16078972)</Keyword>
<Keyword MajorTopicYN="N">Geranylgeranylpyrophosphate (PubChem CID: 44134732)</Keyword>
<Keyword MajorTopicYN="N">Leukemia</Keyword>
<Keyword MajorTopicYN="N">Lovastatin (PubChem CID: 53232)</Keyword>
<Keyword MajorTopicYN="N">Mevalonate (PubChem CID: 439230)</Keyword>
<Keyword MajorTopicYN="N">Ro 48-8071 (PubChem CID: 1949)</Keyword>
<Keyword MajorTopicYN="N">Simvastatin (PubChem CID: 54454)</Keyword>
<Keyword MajorTopicYN="N">Squalene (PubChem CID: 25244109)</Keyword>
<Keyword MajorTopicYN="N">Statins</Keyword>
</KeywordList>
</MedlineCitation>
<PubmedData>
<History>
<PubMedPubDate PubStatus="received">
<Year>2015</Year>
<Month>04</Month>
<Day>29</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="revised">
<Year>2015</Year>
<Month>09</Month>
<Day>02</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="accepted">
<Year>2015</Year>
<Month>09</Month>
<Day>02</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez">
<Year>2015</Year>
<Month>9</Month>
<Day>12</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="pubmed">
<Year>2015</Year>
<Month>9</Month>
<Day>12</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline">
<Year>2016</Year>
<Month>8</Month>
<Day>9</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList>
<ArticleId IdType="pubmed">26358205</ArticleId>
<ArticleId IdType="pii">S0014-2999(15)30237-5</ArticleId>
<ArticleId IdType="doi">10.1016/j.ejphar.2015.09.004</ArticleId>
</ArticleIdList>
</PubmedData>
</pubmed>
<affiliations>
<list>
<country>
<li>Serbie</li>
</country>
</list>
<tree>
<country name="Serbie">
<noRegion>
<name sortKey="Vilimanovich, Urosh" sort="Vilimanovich, Urosh" uniqKey="Vilimanovich U" first="Urosh" last="Vilimanovich">Urosh Vilimanovich</name>
</noRegion>
<name sortKey="Bogdanovic, Andrija" sort="Bogdanovic, Andrija" uniqKey="Bogdanovic A" first="Andrija" last="Bogdanovic">Andrija Bogdanovic</name>
<name sortKey="Bosnjak, Mihajlo" sort="Bosnjak, Mihajlo" uniqKey="Bosnjak M" first="Mihajlo" last="Bosnjak">Mihajlo Bosnjak</name>
<name sortKey="Bumbasirevic, Vladimir" sort="Bumbasirevic, Vladimir" uniqKey="Bumbasirevic V" first="Vladimir" last="Bumbasirevic">Vladimir Bumbasirevic</name>
<name sortKey="Isakovic, Aleksandra" sort="Isakovic, Aleksandra" uniqKey="Isakovic A" first="Aleksandra" last="Isakovic">Aleksandra Isakovic</name>
<name sortKey="Kravic Stevovic, Tamara" sort="Kravic Stevovic, Tamara" uniqKey="Kravic Stevovic T" first="Tamara" last="Kravic-Stevovic">Tamara Kravic-Stevovic</name>
<name sortKey="Markovic, Ivanka" sort="Markovic, Ivanka" uniqKey="Markovic I" first="Ivanka" last="Markovic">Ivanka Markovic</name>
<name sortKey="Mircic, Aleksandar" sort="Mircic, Aleksandar" uniqKey="Mircic A" first="Aleksandar" last="Mircic">Aleksandar Mircic</name>
<name sortKey="Trajkovic, Vladimir" sort="Trajkovic, Vladimir" uniqKey="Trajkovic V" first="Vladimir" last="Trajkovic">Vladimir Trajkovic</name>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Bois/explor/RapamycinFungusV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000C16 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 000C16 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Bois
   |area=    RapamycinFungusV1
   |flux=    Main
   |étape=   Exploration
   |type=    RBID
   |clé=     pubmed:26358205
   |texte=   Statin-mediated inhibition of cholesterol synthesis induces cytoprotective autophagy in human leukemic cells.
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i   -Sk "pubmed:26358205" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd   \
       | NlmPubMed2Wicri -a RapamycinFungusV1 

Wicri

This area was generated with Dilib version V0.6.38.
Data generation: Thu Nov 19 21:55:41 2020. Site generation: Thu Nov 19 22:00:39 2020